Categories

• Announcements

  Announcements regarding our community

  0
  Topics
  0
  Posts
  No new posts.
• Tours

  A place for patient and healthcare professional feedback.

  5
  Topics
  5
  Posts

  A

  Enter your comments here.
• About

  Want to know more about the organization, strategic plan, services, and fee schedule? Ask here.

  1
  Topics
  2
  Posts

  

  @NatBourre You can see the link to the community guidelines in the top right corner of the forum or it will be a link available on all pages of the updated PAAB website.
• PAAB Forum Tutorials

  Have questions about how to use the forum, set up your account, functionality etc.? Ask them here and we'll help you out.

  1
  Topics
  1
  Posts

  A

  Lets start with a quick registration video.
• Newsletters/Blogs

  Blog posts from individual members

  4
  Topics
  23
  Posts

  

  Great question @jen_antibody Assuming that the email template was submitted to meet the restrictions outlined in the second paragraph under “Dissemination” above, you would not be required to resubmit the template. Yes, you should provide the “attachment name” within it’s submission and convey that the intent is to disseminate through the approved template (efile #). No, you are not required to resubmit the template due to updates to pieces which were previously listed through the template. Let us know if you have any further questions.
• PAAB Code

  Do you have questions about particular sections of the PAAB code? Do you have insights on how sections of the code be improved? Do you want to share insights about how related standards are addressed in other jurisdictions? Post here.

  15
  Topics
  16
  Posts

  

  Hey @AnetteCPC This would not be acceptable as the cookies would be placed on the computer, but they would not be able verify who is using that computer. If an HCP was to sign into a verified site on a shared computer, sign out and leave that computer, the next user would be exposed to advertising without verification that they are an HCP. This would contravene consumer regulations.
• Events & Training

  Have more questions about training? Let us know.

  0
  Topics
  0
  Posts
  No new posts.
• Resources

  Guidance on Code Application

  Guidance on Submission Procedures

  Guidance on DTCA / DTCI Regulations

  Newsletters

  PAAB Icons

  Activities

  External Resources
  68
  Topics
  73
  Posts

  A

  Enter your comments on this document here.
• PAAB Q&A

  Claims & Support/References for Claims

  Non-product branded APS, pre-NOC teasers

  NHP, OTC

  CME, educational material, Reprints, reports, textbooks, independently created content

  DTCA/I, consumer secondary audience

  Electronic Media

  FYI post-approval change/preclearance exemption/what requires review/PAAB scope

  Miscellaneous

  Disclosure requirements: PI & Safety Information, Federal schedule, study parameters, reference lists

  Giveaways, Incentives & GIfts, contests, coupons (maybe activities)

  International Conferences

  Linkage Issues

  Patient Info

  Press Releases, Financial Reports, Unsolicited Requests

  Sampling

  Submission Requirements/process & Timelines/eFiles

  Terms of Market Authorization

  Visuals/Layout
  739
  Topics
  765
  Posts

  

  You are correct in your assumption that this would brand the email and its content. When we link branded and unbranded, everything becomes branded. As the sign-off is content within the entirety of the message, the disease content becomes branded and needs to be reviewed in this context. Note that this would also trigger code section 2.10.1 and 2.4, requiring the inclusion of the indication and fair balance.